Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion 
The MUHC Foundation’s Le Bal Rouge Gala Raises a record-breaking $2,050,000 million for Cancer Research at the MUHC
The MUHC Foundation backs the most innovative cancer researchers in the province. This year’s Le Bal Rouge gala supported the...
Keros Therapeutics to Host a Corporate Update Conference Call and Webcast
LEXINGTON, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company...
Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
NEW HOPE, Pa., June 04, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”),...
Indaptus Therapeutics to Present New Positive Data on Decoy20 at Next-Gen Immuno-Oncology Conference
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to...
4DMT Announces Presentations at Clinical Trials at the Summit 2024 Meeting
• 24-week injection-free subgroup analyses from the Randomized Phase 2 Dose Expansion Stage of PRISM Trial Evaluating 4D-150 in wet...
Soleno Therapeutics Set to Join Russell 3000® Index
REDWOOD CITY, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing...
Interpace Diagnostics Announces New Data Analyzing Imbalance of Short Tandem Repeat Alleles for Pancreatic Cancer Detection Published as an ASCO 2024 Abstract
PARSIPPANY, NJ, June 04, 2024 (GLOBE NEWSWIRE) -- Interpace Diagnostics®, a subsidiary of Interpace Biosciences® (OTCQX: IDXG), is proud to...
Surplus Solutions Announces Major Expansion of Operations with New 37,000 Sq Ft Warehouse in Murrieta, CA
WOONSOCKET, R.I., June 04, 2024 (GLOBE NEWSWIRE) -- Surplus Solutions, a leader in Equipment Lifecycle Management (ELM) services, announces the...
MangoRx to Introduce “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances
MOJO to be offered as an Oral Dissolvable Tablet (ODT) marketed to younger male demographic as an alternative to PRIME...
Apollomics Announces Vebreltinib Data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Data from Phase 2 and 2/3 trials demonstrate continued efficacy and safety of vebreltinib for treating different tumor types carrying...
Akari Therapeutics Secures $7.6 Million in Upsized Financing Round
BOSTON and LONDON, June 04, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics Plc (Nasdaq: AKTX), an innovative biotechnology company advancing therapies...
BioVie Announces Formation of Advisory Board for Bezisterim in Long COVID
Scientific Advisory Board to play pivotal role in guiding and accelerating bezisterim long COVID Phase 2b trial supported by an...
April Boyce Joins PetVivo Holdings, Inc. as the Vice President of Marketing
PetVivo Holdings, Inc. April Boyce MINNEAPOLIS, MN, US, June 04, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC Pink: PETV...
BridgeBio Announces Durable Month 12 and 18 Phase 2 Cohort 5 Results of Oral Infigratinib in Achondroplasia, and First Participant Consented in ACCEL for Hypochondroplasia
- In Cohort 5 of PROPEL 2 (0.25 mg/kg/day), oral treatment with infigratinib resulted in a statistically significant and sustained...
Amarin Board of Directors Announces CEO Transition
-- Board Appoints Aaron Berg as President & CEO -- -- Patrick Holt to Step Down as President & CEO...
FendX Announces Fourth Real-World Testing Site for REPELWRAP(TM) Film with Draganfly Inc.
Nanotechnology performance from testing will provide insights to continue to advance towards commercial productionOakville, Ontario--(Newsfile Corp. - June 4, 2024)...
Amphastar Announces Additional $50 Million Increase to its Share Buyback Program
RANCHO CUCAMONGA, CA / ACCESSWIRE / June 4, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today announced that on June 3,...
CardioComm Solutions to Settle Outstanding Debt with Shares
Toronto, Ontario--(Newsfile Corp. - June 3, 2024) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical...
Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting,...
Hyperfine, Inc. to Host Analyst and Investor Education Webcast with Clinical and Brain Imaging Experts on June 25, 2024
- Led by Edmond Knopp, MD, VP of Medical Affairs - Welcoming three KOLs to discuss clinical developments in ultra-low-field...